We've found
12,214
archived clinical trials in
Women's Studies
We've found
12,214
archived clinical trials in
Women's Studies
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Updated: 12/31/1969
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials